Close Menu

NEW YORK – Invitae today announced a partnership with BioMarin Pharmaceuticals on a program to expand access to genetic testing for skeletal dysplasias. 

The companies have launched Discover Dysplasias to offer genetic testing at no charge to patients who show signs or symptoms of having a skeletal dysplasia. These rare, mostly genetic disorders, of which there are hundreds of types, affect bones and joints.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Aug
12
Sponsored by
Truvian

Antibody testing is expected to play an important role in the management of the COVID-19 pandemic. 

Aug
18

As worldwide COVID-19 cases continue to rise, there is a significant need to increase testing and population surveillance capacity.

Oct
09
Sponsored by
PerkinElmer

As cases of COVID-19 continued to grow this spring and summer in the US, so too did the number of Emergency Use Authorizations from the FDA for clinical diagnostic tests aimed at detecting current and past infections.